ADVANCED ACCELERATOR APPLICATIONS USA INC

ADVANCED ACCELERATOR APPLICATIONS USA INC (France) holds 1 active US FDA Type II Drug Master File and 2 inactive, has DMF or CEP filings on record for 1 active ingredient and is linked to 4 FDA-registered manufacturing sites. 10 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “ADVANCED ACCELERATOR APPLICATIONS USA INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/advanced-accelerator-applications-usa-inc

Overview

ADVANCED ACCELERATOR APPLICATIONS USA INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering LUTETIUM [177 LU] TRICHLORIDE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which ADVANCED ACCELERATOR APPLICATIONS USA INC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

ADVANCED ACCELERATOR APPLICATIONS USA INC holds 1 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LUTETIUM [177 LU] TRICHLORIDEActive2017-05-02
  • LYSINE HYDROCHLORIDE (HCI)-ARGININE HYDROCHLORIDE (HCI), 2.5%, SOLUTIONInactive2016-09-26
  • KIT FOR PREPARATION OF 99M TC-RHANNEXIN V-128Inactive2015-03-10

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to ADVANCED ACCELERATOR APPLICATIONS USA INC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

10 FDA enforcement records linked to this company.

  • 4832026-08-11

    Component written specification

  • recall — Class II2024-10-09

    CGMP deviations

  • recall — Class III2023-08-23

    Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date

  • 4832022-11-03

    Absence of Written Procedures

  • 4832022-11-03

    Procedures not in writing, fully followed

  • 4832022-11-03

    Calibration/Inspection/Checking not done

  • 4832022-11-03

    Investigations of discrepancies, failures

  • 4832022-11-03

    Procedures for sterile drug products

  • recall — Class III2022-04-13

    Subpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.

  • recall — Class II2020-01-29

    Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).

For suppliers

Is this ADVANCED ACCELERATOR APPLICATIONS USA INC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.